Provenge, located in Seattle, WA, offers personalized immunotherapy for men with advanced prostate cancer. This FDA-approved treatment activates the immune system to fight metastatic castration-resistant prostate cancer, potentially extending the lives of certain individuals.
Utilizing the patient's own immune cells, Provenge works uniquely from traditional cancer therapies, training the immune system to target and attack prostate cancer cells. With a well-established safety profile and a short treatment course, Provenge is a specialized approach for those with aggressive forms of prostate cancer.
Generated from the website